Helius Medical Stock Jumps 19% as CMS Assigns HCPCS Codes for PoNS Devices

Monday, 4 March 2024, 18:05

Helius Medical Technologies (HSDT) experienced a significant 19% increase in its stock price following the announcement that the Centers for Medicare and Medicaid Services (CMS) had assigned HCPCS codes for Helius's innovative PoNS devices intended for Multiple Sclerosis patients. The assignment of these codes has boosted investor confidence in the potential market growth and adoption of Helius's groundbreaking technology.
https://store.livarava.com/56fbbfb6-da53-11ee-b8c9-5254a2021b2b.jpe
Helius Medical Stock Jumps 19% as CMS Assigns HCPCS Codes for PoNS Devices

Helius Medical Technologies Surges 19% on CMS Code Assignments

Helius Medical Technologies (HSDT) stock shot up 19% on news the Centers for Medicare and Medicaid Services had assigned HCPCS codes for Helius's PoNS devices for MS.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe